Clinical Trial: Ketamine for Multiple Sclerosis Fatigue (INKLING-MS)
In this study, we aim to show the effect of ketamine on fatigue in 110 people with MS and fatigue, ages 18 to 65. Ketamine is a medication that indirectly increases the release of glutamate (an important chemical messenger) in the brain. We are recruiting 110 people with MS f...
Get Details